Becker's Healthcare September 22, 2022
Here are seven recent headlines involving CMS Becker’s has reported since Sept. 1.
Star ratings for many Medicare Advantage plans are likely to decline next year because of the end of pandemic-era policies and changes in CMS’ methodology, according to a Sept. 15 report from McKinsey. Analysts estimated plans could see $800 million in financial impacts from the rating changes.
COVID-19 vaccines, including updated boosters tailored to the omicron variant, will be provided at no cost, regardless of insurance status, the agency said Sept. 13.
CMS approved expanding Medicaid...